Skip to main content
. 2016 Aug 31;7(40):65441–65453. doi: 10.18632/oncotarget.11761

Figure 5. Immunohistochemical staining for CD68, ObR, and IL-8 of human breast tissue specimens.

Figure 5

Representative images of IHC staining for CD68, ObR, and IL-8 of human breast tissues with benign breast disease, breast carcinoma in situ, or invasive breast carcinoma. *represents significant difference between breast carcinoma in situ (S) and benign tissue (B), P < 0.05. **represents significant difference between invasive breast carcinoma (I) and benign tissue (B), P < 0.01.